What is Centene?
Government managed care company with $194.777B of 2025 revenue and enterprise healthcare scale.
- Category
- Government managed care
- Headquarters
- St. Louis, MO
- Founded
- 1984
- Employees
- 60,000+
- Total funding
- Public company; no VC funding
- Status
- NYSE: CNC; ~$30B market cap
What is Centene?
Centene is a public government managed care company headquartered in St. Louis, MO. It reported $194.777B of 2025 revenue and operates at global enterprise scale.
Centene operates in government managed care with a portfolio spanning Medicaid, Marketplace, Medicare, and specialty/government services. The company reported $194.777B of 2025 revenue, employs about 60,000+, and trades as NYSE: CNC. Its customer base is large, regulated, and relationship-driven, with purchasing decisions shaped by clinical outcomes, compliance, reimbursement, operating leverage, and long-term supply reliability.
The company's scale comes from durable demand in healthcare, recurring consumables or services, installed bases, payer or provider relationships, and disciplined capital allocation. Unlike early-stage software companies, Centene is evaluated through revenue growth, margins, cash flow, reimbursement exposure, procedure or prescription volume, quality, and regulatory execution.
For sellers, Centene is not a single buying center. The practical map includes procurement, finance, clinical, IT, security, compliance, operations, supply chain, commercial teams, and business-unit executives. Strong pitches connect directly to patient outcomes, cost-to-serve, risk reduction, revenue capture, uptime, or measurable productivity.
What does Centene offer?
Centene offers healthcare products and services across Medicaid, Marketplace, Medicare, and specialty/government services.
- Medicaid managed care· Government
- Marketplace plans· Exchange
- Medicare Advantage· Government
- Specialty services· Services
- Behavioral health· Care services
- Pharmacy programs· Pharmacy
- Population health· Care management
How does Centene make money?
Centene earns premium and service revenue from state Medicaid contracts, ACA Marketplace plans, Medicare products, and related specialty health services.
Centene earns premium and service revenue from state Medicaid contracts, ACA Marketplace plans, Medicare products, and related specialty health services. In 2025, that model produced $194.777B of revenue, showing the scale of the installed base, service footprint, payer/provider contracts, or distribution volume behind the business.
Pricing is state-contract-, CMS-bid-, risk-adjustment-, rate-cell-, Marketplace-premium-, and medical-cost-trend driven; economics depend on membership, acuity, utilization, quality, and administrative efficiency. That makes the relevant "pricing tier" for sellers an enterprise contracting motion: account segmentation, compliance review, value analysis, legal terms, security review, reimbursement impact, and multi-year renewal economics.
Growth is driven by a mix of market expansion, procedure or prescription volume, product launches, acquisitions, geographic reach, contract renewals, operational efficiency, and technology adoption. Vendors should expect rigorous procurement, documented ROI, data-security requirements, and evidence that the product can work inside regulated healthcare operations.
Who leads Centene?
Centene is led by Sarah M. London, with finance, operations, clinical, technology, and business-unit leaders shaping major enterprise decisions.
- Sarah M. LondonChief Executive OfficerCEO since 2022Leads Centene's government-program focus and operational reset.
- Drew AsherExecutive Vice President and Chief Financial OfficerCFO since 2021Finance leader for rate cycles, capital allocation, and public reporting.
- Susan SmithChief Operating OfficerSenior executive leadershipOperations leader focused on execution and member experience.
- Dr. Alice Hm ChenChief Health OfficerSenior executive leadershipClinical strategy and health-equity leader.
How do you contact Centene's leadership?
Centene publishes investor-relations, media, supplier, customer, and compliance channels, but it does not publish verified personal executive emails for the listed leaders. Use the public investor-relations route (investorrelations@centene.com) or official contact forms rather than guessed personal addresses.
investorrelations@centene.com is a public investor/contact route; personal executive email format not verifiedHow much funding has Centene raised?
Centene is a mature public company, not a venture-backed startup. It trades as NYSE: CNC, had an approximate ~$30B market capitalization in June 2026, and funds growth through operating cash flow, debt markets, public equity access, and acquisition capacity.
Centene's capital history is a public-company story rather than a disclosed venture-round history. The relevant milestones are founding in 1984, public-market access, acquisitions, debt capacity, dividends or buybacks where applicable, and reinvestment in regulated healthcare capabilities.
The company reported $194.777B of 2025 revenue and operates with the financing tools expected of a large public healthcare company. Capital is directed toward product development, clinical evidence, facilities, inventory, technology, acquisitions, compliance, reimbursement capabilities, and shareholder returns depending on the business model.
Seller signal: Centene has meaningful buying power, but budget access is tied to risk, ROI, compliance, and executive sponsorship. Vendors should map proposals to cost reduction, growth, care quality, automation, supply resilience, cybersecurity, data quality, or measurable operating improvement.
How did Centene get here?
Centene grew through founding, public-market scale, product expansion, acquisitions, and healthcare-market execution.
- 1984Company foundedCentene begins as a Medicaid managed-care company.
- 2001IPOCentene becomes publicly traded.
- 2020WellCare acquiredCentene expands Medicare and government-program scale.
- 2022Sarah London becomes CEOCentene begins a strategic and operational reset.
- 2025$194.777B revenueCentene reports large growth in total revenue.
- 2026Guidance announcedThe company issues 2026 guidance after a volatile government-plan year.
Who are Centene's competitors?
Centene competes with companies that overlap in customers, budgets, clinical categories, distribution channels, or healthcare services.
- Elevance HealthMedicaid, Medicare, commercial, and Carelon competitor.
- UnitedHealthcareManaged-care competitor across Medicaid, Medicare, and commercial.
- Molina HealthcareGovernment managed-care competitor focused on Medicaid and Marketplace.
- CVS HealthAetna Medicaid, Medicare, and Marketplace competitor.
- HumanaMedicare Advantage and government-plan competitor.
Centene — frequently asked questions
